¥3793.00
¥-30.00 (-0.78%)
End-of-day quote: 05/13/2024
TSE:4530
Hisamitsu Pharmaceutical Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $151.22 | $174.55 | 0.00% | 3 | $363.94B |
| NOVN | Novartis | SWX | Hold | CHF93.07 | CHF105.00 | 0.00% | 9 | CHF189.90B |
| SAN | Sanofi | ENXTPA | Outperform | 92.71€ | 102.80€ | 0.00% | 9 | 115.76€B |
| MMM | 3M | NYSE | Hold | $99.63 | $109.39 | 0.00% | 3 | $55.13B |
| RKT | Reckitt Benckiser Group | LSE | Outperform | £45.99 | £66.68 | 0.00% | 12 | £32.36B |
| BAYN | Bayer | XTRA | Hold | 29.38€ | 45.15€ | 0.00% | 4 | 28.86€B |
| VTRS | Viatris Inc | NASDAQ | Hold | $11.36 | $11.73 | 0.00% | 5 | $13.32B |
| H02 | Haw Par Corporation | SGX | - | $9.68 | $17.00 | 0.00% | 0 | $2.14B |
